194 related articles for article (PubMed ID: 21980679)
1. Update on dabigatran for stroke prevention in atrial fibrillation.
Henry DM
Conn Med; 2011 Sep; 75(8):479-83. PubMed ID: 21980679
[No Abstract] [Full Text] [Related]
2. Dabigatran for stroke prevention in all patients with atrial fibrillation?
Hunchuck JE; Lake JD
Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
[No Abstract] [Full Text] [Related]
3. An anticoagulation option for nonvalvular atrial fibrillation.
Shaheen MH; Das P; Koshy SK; Jha SK; Kabra R
J Fam Pract; 2012 Jun; 61(6):E1-6. PubMed ID: 22670241
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
Flaker G; Ezekowitz M; Yusuf S; Wallentin L; Noack H; Brueckmann M; Reilly P; Hohnloser SH; Connolly S
J Am Coll Cardiol; 2012 Feb; 59(9):854-5. PubMed ID: 22361407
[No Abstract] [Full Text] [Related]
5. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens I; Lip GY; Peter K
Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
[No Abstract] [Full Text] [Related]
6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
7. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
Calvo Romero JM
Rev Clin Esp; 2011 Mar; 211(3):142-6. PubMed ID: 21371701
[TBL] [Abstract][Full Text] [Related]
8. Place of dabigatran in contemporary pharmacotherapy.
Gums JG
Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
Shah SV; Gage BF
Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
[TBL] [Abstract][Full Text] [Related]
10. Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation?
Rahme RJ; Bernstein R; Batjer HH; Bendok BR
Neurosurgery; 2011 Feb; 68(2):N16-7. PubMed ID: 21654569
[No Abstract] [Full Text] [Related]
11. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Wann LS; Curtis AB; Ellenbogen KA; Estes NA; Ezekowitz MD; Jackman WM; January CT; Lowe JE; Page RL; Slotwiner DJ; Stevenson WG; Tracy CM; Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Kay GN; Le Heuzey JY; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann LS; Jacobs AK; Anderson JL; Albert N; Creager MA; Ettinger SM; Guyton RA; Halperin JL; Hochman JS; Kushner FG; Ohman EM; Stevenson WG; Yancy CW;
Circulation; 2011 Mar; 123(10):1144-50. PubMed ID: 21321155
[No Abstract] [Full Text] [Related]
12. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
Marín F; Roldán V; Lip GY
Expert Opin Pharmacother; 2012 Jun; 13(8):1087-90. PubMed ID: 22568622
[No Abstract] [Full Text] [Related]
13. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
[TBL] [Abstract][Full Text] [Related]
14. Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.
Clemens A; Haertter S; Friedman J; Brueckmann M; Stangier J; van Ryn J; Lehr T
Curr Med Res Opin; 2012 Feb; 28(2):195-201. PubMed ID: 22208675
[TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulants for stroke prevention in atrial fibrillation.
Taylor J
Eur Heart J; 2012 Jun; 33(12):1419-20. PubMed ID: 22880211
[No Abstract] [Full Text] [Related]
16. Use of dabigatran to prevent stroke in patients with atrial fibrillation.
Mooney T
Nurs Stand; 2013 Mar 6-12; 27(27):35-41. PubMed ID: 23556305
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation: what the GP needs to know].
Diener HC; Kaeufer T; Bode C
MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
[No Abstract] [Full Text] [Related]
18. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).
Pengo V; Crippa L; Falanga A; Finazzi G; Marongiu F; Palareti G; Poli D; Testa S; Tiraferri E; Tosetto A; Tripodi A; Manotti C;
Thromb Haemost; 2011 Nov; 106(5):868-76. PubMed ID: 21946939
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Escobar C; Barrios V; Jimenez D
Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].
Sternotte A; Douxfils J; Chatelain B; Chatelain C; Mullier F; Dogné JM; Spinewine A
J Pharm Belg; 2012 Mar; (1):8-17. PubMed ID: 22536678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
